TUBB4B
Basic information
Region (hg38): 9:137241287-137243707
Previous symbols: [ "TUBB2C" ]
Links
Phenotypes
GenCC
Source:
- Leber congenital amaurosis with early-onset deafness (Strong), mode of inheritance: AD
- Leber congenital amaurosis with early-onset deafness (Strong), mode of inheritance: AD
- Leber congenital amaurosis with early-onset deafness (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leber congenital amaurosis with early-onset deafness | AD | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Ophthalmologic | 29198720 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TUBB4B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 68 | 76 | ||||
missense | 11 | 13 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 7 | 2 | 11 | ||
non coding | 14 | |||||
Total | 0 | 2 | 13 | 76 | 14 |
Variants in TUBB4B
This is a list of pathogenic ClinVar variants found in the TUBB4B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-137241299-G-T | Benign (May 25, 2021) | |||
9-137241332-C-A | Benign (May 25, 2021) | |||
9-137241340-CCCG-C | TUBB4B-related disorder | Benign (Nov 01, 2024) | ||
9-137241340-CCCGCCGCCG-C | TUBB4B-related disorder | Likely benign (Nov 25, 2020) | ||
9-137241340-C-CCCGCCG | TUBB4B-related disorder | Likely benign (Jan 08, 2024) | ||
9-137241372-C-T | TUBB4B-related disorder | Benign (Jul 06, 2023) | ||
9-137241378-C-T | Likely benign (Dec 15, 2023) | |||
9-137241379-T-G | not specified | Uncertain significance (May 04, 2022) | ||
9-137241387-C-T | Likely benign (Dec 22, 2023) | |||
9-137241408-C-A | Likely benign (May 23, 2023) | |||
9-137241427-C-T | Benign (Jun 06, 2023) | |||
9-137241432-C-T | Likely benign (Oct 25, 2022) | |||
9-137241705-C-T | Likely benign (Nov 20, 2023) | |||
9-137241714-C-T | Likely benign (Jun 07, 2023) | |||
9-137241716-T-TG | Likely benign (Dec 16, 2023) | |||
9-137241718-T-C | Uncertain significance (Sep 25, 2023) | |||
9-137241723-T-C | Likely benign (Jun 10, 2023) | |||
9-137241739-G-C | Likely pathogenic (Mar 09, 2022) | |||
9-137241747-C-T | Likely benign (Jan 01, 2023) | |||
9-137241771-C-T | Likely benign (Oct 26, 2022) | |||
9-137241774-C-T | Likely benign (Sep 23, 2023) | |||
9-137241780-C-T | Likely benign (Nov 27, 2023) | |||
9-137241783-C-T | TUBB4B-related disorder | Likely benign (Dec 22, 2023) | ||
9-137241786-C-T | Benign (Feb 01, 2023) | |||
9-137241801-C-T | Likely benign (Nov 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TUBB4B | protein_coding | protein_coding | ENST00000340384 | 4 | 2495 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.809 | 0.191 | 125444 | 0 | 3 | 125447 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.50 | 66 | 276 | 0.239 | 0.0000174 | 2955 |
Missense in Polyphen | 15 | 121.34 | 0.12362 | 1379 | ||
Synonymous | -9.11 | 245 | 119 | 2.06 | 0.00000851 | 872 |
Loss of Function | 3.00 | 2 | 14.2 | 0.141 | 6.19e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00000893 | 0.00000883 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.;
- Disease
- DISEASE: Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879]: An autosomal dominant disease characterized by severe retinal degeneration and sensorineural hearing loss. Symptoms occur within the first decade of life. Onset at birth is observed in some patients. {ECO:0000269|PubMed:29198720}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Phagosome - Homo sapiens (human);Gap junction - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Pathogenic Escherichia coli infection;Parkin-Ubiquitin Proteasomal System pathway;Neutrophil degranulation;Post-translational protein modification;Metabolism of proteins;Chaperonin-mediated protein folding;Formation of tubulin folding intermediates by CCT/TriC;Innate Immune System;Immune System;Carboxyterminal post-translational modifications of tubulin;Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Protein folding;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Prefoldin mediated transfer of substrate to CCT/TriC;Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding;Post-chaperonin tubulin folding pathway;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.388
Intolerance Scores
- loftool
- rvis_EVS
- -1
- rvis_percentile_EVS
- 8.32
Haploinsufficiency Scores
- pHI
- 0.234
- hipred
- Y
- hipred_score
- 0.565
- ghis
- 0.626
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Tubb4b
- Phenotype
Zebrafish Information Network
- Gene name
- tubb4b
- Affected structure
- otolith
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;microtubule cytoskeleton organization;mitotic cell cycle;microtubule-based process;regulation of G2/M transition of mitotic cell cycle;natural killer cell mediated cytotoxicity;neutrophil degranulation;ciliary basal body-plasma membrane docking
- Cellular component
- extracellular region;nucleus;cytoplasm;cytosol;cytoskeleton;microtubule;azurophil granule lumen;myelin sheath;extracellular exosome;extracellular vesicle
- Molecular function
- double-stranded RNA binding;GTPase activity;structural constituent of cytoskeleton;GTP binding;MHC class I protein binding;unfolded protein binding